| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |